Journal article icon

Journal article

Cost-utility analysis of tenofovir disoproxil fumarate in the treatment of chronic hepatitis B.

Abstract:

OBJECTIVE: The aim of this study was to assess the cost-effectiveness of tenofovir disoproxil fumarate (TDF) in the treatment of chronic hepatitis B (CHB) versus alternative nucleos(t)ides from a UK National Health Service (NHS) perspective. METHODS: A Markov model was used to calculate costs and benefits of nucleos(t)ide strategies in hepatitis B e antigen (HBeAg)-positive and HBeAg-negative patients with hepatitis B virus mono-infection and compensated liver disease. The model included 18 ...

Expand abstract
Publication status:
Published

Actions


Access Document


Authors


Bentley, A More by this author
Dusheiko, G More by this author
Journal:
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Volume:
13
Issue:
8
Pages:
922-933
Publication date:
2010-12-05
DOI:
EISSN:
1524-4733
ISSN:
1098-3015
URN:
uuid:89fc133d-ba39-42a9-817d-4941e15e9748
Source identifiers:
202208
Local pid:
pubs:202208

Terms of use


Metrics



If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP